Author:
da Silva Cecília Rocha,de Andrade Neto João Batista,Sidrim José Júlio Costa,Ângelo Maria Rozzelê Ferreira,Magalhães Hemerson Iury Ferreira,Cavalcanti Bruno Coêlho,Brilhante Raimunda Sâmia Nogueira,Macedo Danielle Silveira,de Moraes Manoel Odorico,Lobo Marina Duarte Pinto,Grangeiro Thalles Barbosa,Nobre Júnior Hélio Vitoriano
Abstract
ABSTRACTThere have recently been significant increases in the prevalence of systemic invasive fungal infections. However, the number of antifungal drugs on the market is limited in comparison to the number of available antibacterial drugs. This fact, coupled with the increased frequency of cross-resistance, makes it necessary to develop new therapeutic strategies. Combination drug therapies have become one of the most widely used and effective strategies to alleviate this problem. Amiodarone (AMD) is classically used for the treatment of atrial fibrillation and is the drug of choice for patients with arrhythmia. Recent studies have shown broad antifungal activity of the drug when administered in combination with fluconazole (FLC). In the present study, we induced resistance to fluconazole in six strains ofCandida tropicalisand evaluated potential synergism between fluconazole and amiodarone. The evaluation of drug interaction was determined by calculating the fractional inhibitory concentration and by performing flow cytometry. We conclude that amiodarone, when administered in combination with fluconazole, exhibits activity against strains ofC. tropicalisthat are resistant to fluconazole, which most likely occurs via changes in the integrity of the yeast cell membrane and the generation of oxidative stress, mitochondrial dysfunction, and DNA damage that could lead to cell death by apoptosis.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference59 articles.
1. Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections;Horn;Diagn. Microbiol. Infect. Dis.,2007
2. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry;Horn;Clin. Infect. Dis.,2009
3. Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method;Pfaller;Diagn. Microbiol. Infect. Dis.,2011
4. Epidemiology of invasive candidiasis: a persistent public health problem;Pfaller;Clin. Microbiol. Rev.,2007
5. Antifungal susceptibility of bloodstream Candida isolates in Sfax hospital, Tunisia;Sellami;Mycopathologia,2011
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献